Detalhe da pesquisa
1.
Risk Factors, Hyaluronidase Expression, and Clinical Immunogenicity of Recombinant Human Hyaluronidase PH20, an Enzyme Enabling Subcutaneous Drug Administration.
AAPS J
; 24(6): 110, 2022 10 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36266598
2.
PH20 is not expressed in murine CNS and oligodendrocyte precursor cells.
Ann Clin Transl Neurol
; 4(3): 191-211, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28275653